Literature DB >> 21397168

Arcuate fasciculus and speech in congenital bilateral perisylvian syndrome.

Anita S D Saporta1, Ajay Kumar, Rajkumar M Govindan, Senthil K Sundaram, Harry T Chugani.   

Abstract

Standard magnetic resonance imaging can diagnose congenital bilateral perisylvian polymicrogyria, but is limited in explaining the heterogeneous clinical spectrum of the related congenital bilateral perisylvian syndrome, characterized by pseudobulbar dysfunction, developmental delay, and epilepsy. We analyzed arcuate fasciculi using diffusion tensor imaging, a major language tract in the perisylvian region interconnecting the Broca and Wernicke areas, and at high risk of becoming developmentally affected in this condition. Six patients with congenital bilateral perisylvian syndrome underwent diffusion tensor imaging and were evaluated. The arcuate fasciculus was manually isolated, using tractography. The tract was identified in three patients who had developed speech, and whose values for various diffusion parameters were similar to those in age-matched controls (patients/controls means: fractional anisotropy, 0.50/0.52; apparent diffusion coefficient, 0.0022/0.0022 mm(2)/second; P = ns for both). However, in three patients with severe impairment and no speech development, the arcuate fasciculus could not be identified by fiber-tracking. In this small series, the absence of arcuate fasciculi on diffusion tensor imaging correlated with a more severe phenotype, which cannot be appreciated via structural magnetic resonance imaging alone.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21397168     DOI: 10.1016/j.pediatrneurol.2010.11.006

Source DB:  PubMed          Journal:  Pediatr Neurol        ISSN: 0887-8994            Impact factor:   3.372


  8 in total

1.  Altered White Matter Organization in the TUBB3 E410K Syndrome.

Authors:  P Ellen Grant; Kiho Im; Banu Ahtam; Cynthia T Laurentys; Wai-Man Chan; Maya Brainard; Sheena Chew; Marie Drottar; Caroline D Robson; Irene Drmic; Elizabeth C Engle
Journal:  Cereb Cortex       Date:  2019-07-22       Impact factor: 5.357

2.  Quantification and discrimination of abnormal sulcal patterns in polymicrogyria.

Authors:  Kiho Im; Rudolph Pienaar; Michael J Paldino; Nadine Gaab; Albert M Galaburda; P Ellen Grant
Journal:  Cereb Cortex       Date:  2012-09-17       Impact factor: 5.357

3.  Individual variations of the human corticospinal tract and its hand-related motor fibers using diffusion MRI tractography.

Authors:  Kyriakos Dalamagkas; Magdalini Tsintou; Yogesh Rathi; Lauren J O'Donnell; Ofer Pasternak; Xue Gong; Anne Zhu; Peter Savadjiev; George M Papadimitriou; Marek Kubicki; Edward H Yeterian; Nikos Makris
Journal:  Brain Imaging Behav       Date:  2020-06       Impact factor: 3.978

4.  Exome sequencing and diffusion tensor imaging in developmental disabilities.

Authors:  Senthil Sundaram; A H M Huq; Tammy Hsia; Harry Chugani
Journal:  Pediatr Res       Date:  2013-12-06       Impact factor: 3.756

5.  Have You Ever Seen the Impact of Crossing Fiber in DTI?: Demonstration of the Corticospinal Tract Pathway.

Authors:  Dong-Hoon Lee; Ji Won Park; Sung-Hee Park; Cheolpyo Hong
Journal:  PLoS One       Date:  2015-07-02       Impact factor: 3.240

6.  Pediatric traumatic brain injury: language outcomes and their relationship to the arcuate fasciculus.

Authors:  Frédérique J Liégeois; Kate Mahony; Alan Connelly; Lauren Pigdon; Jacques-Donald Tournier; Angela T Morgan
Journal:  Brain Lang       Date:  2013-06-10       Impact factor: 2.381

7.  Independent contribution of individual white matter pathways to language function in pediatric epilepsy patients.

Authors:  Michael J Paldino; Kara Hedges; Wei Zhang
Journal:  Neuroimage Clin       Date:  2014-09-30       Impact factor: 4.881

8.  Auditory-Motor Mapping Training: Comparing the Effects of a Novel Speech Treatment to a Control Treatment for Minimally Verbal Children with Autism.

Authors:  Karen Chenausky; Andrea Norton; Helen Tager-Flusberg; Gottfried Schlaug
Journal:  PLoS One       Date:  2016-11-09       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.